Literature DB >> 8051535

Estimating incidence and prevalence of treated psychiatric disorders from routine statistics: the example of schizophrenia in Oxfordshire.

M Goldacre1, R Shiwach, D Yeates.   

Abstract

STUDY
OBJECTIVE: To use routine statistical records to estimate the incidence and prevalence of treated schizophrenia. DESIGN AND
SETTING: Analysis of linked records in Oxfordshire (population 540,000) for all people in contact with specialist psychiatric services from 1975-86.
SUBJECTS: Records of 685 people with a diagnosis of schizophrenia as an inpatient and a further 294 people who received specialist psychiatric care for schizophrenia outside hospital without any record of inpatient care.
MEASUREMENTS AND MAIN RESULTS: The measures most commonly recorded in psychiatric statistics, first admission rates for people in whom schizophrenia was recorded at their first psychiatric admission, were 8.7 per 100,000 males and 5.6 per 100,000 females. First contact rates for people in whom schizophrenia was recorded at any time in the study period and in any setting were 15.1 per 100,000 males and 11.4 per 100,000 females. Whichever patient population was analysed, the broad profile of schizophrenia by age, sex, and calendar time was similar.
CONCLUSIONS: First admission rates for schizophrenia, as identifiable in current routine information systems, are useful indicators of the general pattern of disease but are inadequate absolute indicators of treated incidence. These data are limited to the first ever contact. Reliable information about the treated incidence of disease requires information systems which incorporate information about when and where each diagnosis was first made. Reliable information about treated prevalence requires systems which also incorporate data about death, recovery, and migration into and out of the study population.

Entities:  

Mesh:

Year:  1994        PMID: 8051535      PMCID: PMC1059967          DOI: 10.1136/jech.48.3.318

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  8 in total

1.  Changes in the incidence of schizophrenia?

Authors:  E Strömgren
Journal:  Br J Psychiatry       Date:  1987-01       Impact factor: 9.319

2.  The problem of detecting changes in the incidence of schizophrenia.

Authors:  R E Kendell; D E Malcolm; W Adams
Journal:  Br J Psychiatry       Date:  1993-02       Impact factor: 9.319

3.  The effect of sex, marriage and age at first admission on the hospitalization of schizophrenics during 2 years following discharge.

Authors:  D C Watt; T K Szulecka
Journal:  Psychol Med       Date:  1979-08       Impact factor: 7.723

Review 4.  Aspects of the epidemiology of schizophrenia.

Authors:  E Hare
Journal:  Br J Psychiatry       Date:  1986-11       Impact factor: 9.319

5.  Sex difference in age at onset of schizophrenia.

Authors:  A W Loranger
Journal:  Arch Gen Psychiatry       Date:  1984-02

6.  Accuracy of diagnosis of psychosis on general practice computer system.

Authors:  I Nazareth; M King; A Haines; L Rangel; S Myers
Journal:  BMJ       Date:  1993-07-03

7.  Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders.

Authors:  N Sartorius; A Jablensky; A Korten; G Ernberg; M Anker; J E Cooper; R Day
Journal:  Psychol Med       Date:  1986-11       Impact factor: 7.723

8.  The schizophrenia diagnosis in Denmark. A register-based investigation.

Authors:  P Munk-Jørgensen
Journal:  Acta Psychiatr Scand       Date:  1985-09       Impact factor: 6.392

  8 in total
  12 in total

1.  Computing disease incidence, prevalence and comorbidity from electronic medical records.

Authors:  Steven C Bagley; Russ B Altman
Journal:  J Biomed Inform       Date:  2016-08-04       Impact factor: 6.317

2.  Cost of schizophrenia to UK Society. An incidence-based cost-of-illness model for the first 5 years following diagnosis.

Authors:  J F Guest; R F Cookson
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

3.  Depression and anxiety in people with inflammatory bowel disease.

Authors:  L M Kurina; M J Goldacre; D Yeates; L E Gill
Journal:  J Epidemiol Community Health       Date:  2001-10       Impact factor: 3.710

4.  Psychiatric disorders certified on death certificates in an English population.

Authors:  Michael J Goldacre; Marie E Duncan; Myfanwy Griffith; Paula Cook-Mozaffari
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-02-08       Impact factor: 4.328

Review 5.  The burden of schizophrenia on caregivers: a review.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 6.  Schizophrenia: shifting the balance of care.

Authors:  S Kavanagh; L Opit; M Knapp; J Beecham
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-08       Impact factor: 4.328

Review 7.  Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses.

Authors:  James B Kirkbride; Antonia Errazuriz; Tim J Croudace; Craig Morgan; Daniel Jackson; Jane Boydell; Robin M Murray; Peter B Jones
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

8.  Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006.

Authors:  Uy Hoang; Robert Stewart; Michael J Goldacre
Journal:  BMJ       Date:  2011-09-13

Review 9.  A systematic review of the prevalence of schizophrenia.

Authors:  Sukanta Saha; David Chant; Joy Welham; John McGrath
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

Review 10.  A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology.

Authors:  John McGrath; Sukanta Saha; Joy Welham; Ossama El Saadi; Clare MacCauley; David Chant
Journal:  BMC Med       Date:  2004-04-28       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.